Nanosonics Limited
Nanosonics Limited
- P/E ratio
- 50.25
Your view on NAN.AX
Overview
What the company does, where it operates, and who runs it.
About Nanosonics Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael C. Kavanagh
- Headquarters
- Building A, Macquarie Park, NSW, AU
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael C. Kavanagh
- Headquarters
- Building A, Macquarie Park, NSW, AU
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories.
Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies.
Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows.
Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Nanosonics Limited from FRC's valuation model, read against the market price. NAN.AX last traded at AUD 3.57, 50.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Nanosonics Limited. Starting points for Nanosonics Limited: P/E 50.3, EPS AUD 0.06, beta 1.22 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Nanosonics Limited. Nanosonics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Nanosonics Limited. Trailing twelve-month EPS for Nanosonics Limited stands at AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.03 | AUD 0.03 | AUD 0.05 |
| Lowest estimate | AUD 0.00 | AUD 0.03 | AUD 0.02 | AUD 0.02 |
| Highest estimate | AUD 0.00 | AUD 0.03 | AUD 0.04 | AUD 0.07 |
| Number of analysts | 0 | 1 | 5 | 5 |
| A year ago | −AUD 0.001 | AUD 0.03 | AUD 0.06 | — |
| Growth vs a year ago | — | +1.2% | −42.9% | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 109.58M | AUD 104.59M | AUD 219.05M | AUD 239.00M |
| Lowest estimate | AUD 109.58M | AUD 104.59M | AUD 214.39M | AUD 223.71M |
| Highest estimate | AUD 109.58M | AUD 104.59M | AUD 223.39M | AUD 250.61M |
| Number of analysts | 6 | 1 | 7 | 7 |
| A year ago | AUD 60.39M | AUD 85.72M | AUD 203.47M | — |
| Growth vs a year ago | +81.5% | +22.0% | +7.7% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Nanosonics Limited. Nanosonics Limited has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AHC.AXAustco Healthcare Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| ANN.AXAnsell Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| TRJ.AXTrajan Group Holdings Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SSSGYSartorius AG | Healthcare | OTC | $15.8B | ||
| STAASTAAR Surgical Company | Healthcare | NASDAQ | $1.3B | ||
| STSSSharps Technology, Inc. | Healthcare | NASDAQ | $53.7M | ||
| STVNStevanato Group S.p.A. | Healthcare | NYSE | $4.2B | ||
| STXSStereotaxis, Inc. | Healthcare | AMEX | $94.8M | ||
| SUVPFSartorius AG | Healthcare | OTC | $18.7B | ||
| SVSOSheerVision, Inc. | Healthcare | OTC | $2,551 | ||
| TCGGYTecan Group AG | Healthcare | OTC | $2.3B | ||
| TCHBFTecan Group AG | Healthcare | OTC | $2.2B | ||
| TDVXFTobii Dynavox AB (publ) | Healthcare | OTC | $981.6M | ||
| TFXTeleflex Incorporated | Healthcare | NYSE | $6.6B | ||
| TGLVYTop Glove Corporation Bhd. | Healthcare | OTC | $1.1B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXUSVanguard Total International Stock ETF | $163.2B in assets | 0.00% | |
| VEAVanguard FTSE Developed Markets ETF | $231.6B in assets | 0.00% | |
| IEFAiShares Core MSCI EAFE ETF | $188.8B in assets | 0.00% | |
| VSSVanguard FTSE All-World ex-US Small-Cap ETF | $11.6B in assets | 0.01% | |
| GWXState Street SPDR S&P International Small Cap ETF | $882M in assets | 0.05% | |
| AVDSAvantis International Small Cap Equity ETF | $379M in assets | 0.02% | |
| DFISDimensional - International Small Cap ETF | $5.8B in assets | 0.01% | |
| IPACiShares Core MSCI Pacific ETF | $2.6B in assets | 0.01% | |
Largest holders first, then the funds most concentrated in NAN.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Nanosonics Limited. Coverage tracks Nanosonics Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Nanosonics Limited.